Latest news! Board’s 2015/16 annual report published
Systemic Anti-cancer Therapies Clinical Director – Dr Andrew Wardley
Find out more about Andrew
Board membership
See the current membership
Board documents
- Constitution SACT 2014
- SACT Pathway Board Annual Report & Annual Plan 2014
- SACT Pathway Board Annual Report & Annual Plan 2015
- SACT Pathway Board Annual Report & Annual Plan 2016
Guidelines and policies
- Central Venous Access Device Policy
- Guidelines for the use of G-CSF & Pegfilgrastim (Neulasta)
- Guidelines for the use of Antiemetics
- Antiemetics Policy 2015
- Medicines Practice Operational Policy 2016
- Management of Extravasation Policy 2016
- Cytotoxic Spillage and Contamination Policy
- Guidelines for the Management of Sepsis (including Neutropenic Sepsis)
The above documents are the current guidelines and policies. Those that have breached their review date are currently under review and will be updated when the new policy/guideline is ratified.
